iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Vivaldi Capital Management LP

Vivaldi Capital Management LP trimmed its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 36.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,063 shares of the financial services provider’s stock after selling 1,725 shares during the period. Vivaldi Capital Management LP’s holdings in iShares Biotechnology ETF were worth $424,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. HHM Wealth Advisors LLC lifted its holdings in iShares Biotechnology ETF by 200.0% during the fourth quarter. HHM Wealth Advisors LLC now owns 225 shares of the financial services provider’s stock valued at $30,000 after purchasing an additional 150 shares in the last quarter. VSM Wealth Advisory LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $30,000. Bradley & Co. Private Wealth Management LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $32,000. Newbridge Financial Services Group Inc. acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $33,000. Finally, Hager Investment Management Services LLC acquired a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $34,000. 62.45% of the stock is owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Trading Up 1.1%

iShares Biotechnology ETF stock opened at $122.51 on Tuesday. iShares Biotechnology ETF has a 12-month low of $107.43 and a 12-month high of $150.57. The stock has a market cap of $5.28 billion, a P/E ratio of 23.96 and a beta of 0.77. The company has a 50-day moving average price of $123.55 and a 200 day moving average price of $132.50.

iShares Biotechnology ETF Increases Dividend

The company also recently disclosed a dividend, which was paid on Friday, March 21st. Investors of record on Tuesday, March 18th were given a dividend of $0.1212 per share. This is a boost from iShares Biotechnology ETF’s previous dividend of $0.06. The ex-dividend date of this dividend was Tuesday, March 18th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.